Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...
Johnson & Johnson’s rebate model aims to address misuse of 340B Program. HRSA’s threats of penalties led J&J to halt the ...
In trading on Monday, shares of Johnson & Johnson entered into oversold territory, hitting an RSI reading of 29.5 ...
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
Illinois Attorney General Kwame Raoul joins a chorus of reforms advocates who have sounded the alarm about Johnson’s proposal ...
GOP Representative Marjorie Taylor Greene is lashing out at House Speaker Mike Johnson for failing to secure a GOP ...
The Doctor Odyssey star appeared on Thursday’s Live with Kelly and Mark in Palm Springs, where Consuelos reminded him of his ...
On Tuesday, Johnson & Johnson (JNJ) stock saw a decline, ending the day at $152.64 which represents a decrease of $-2.40 or -1.55% from the prior close of $155.04. The stock opened at $154.53 and ...